Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Marin

Showing results (421-430 of 453) with videos related to

Pageof 46
Sort By:
Hepatology (Baltimore, Md.)|September 19, 2017
MicroRNA-506 promotes primary biliary cholangitis-like features in cholangiocytes and immune activationOihane Erice, Patricia Munoz-Garrido, Javier Vaquero, et al.
Journal of Hepatology|June 24, 2022
TREM-2 plays a protective role in cholestasis by acting as a negative regulator of inflammationIbone Labiano, Aloña Agirre-Lizaso, Paula Olaizola, et al.
Clinical Science (London, England : 1979)|September 20, 2024
Non-mitogenic FGF19 mRNA-based therapy for the treatment of experimental metabolic dysfunction-associated steatotic liver disease (MASLD)Amaya Lopez-Pascual, Joan S Russo-Cabrera, Nuria Ardaiz, et al.
Nature Communications|September 4, 2025
Identification of Neuritin 1 as a local metabolic regulator of brown adipose tissueManuela Sánchez-Feutrie, Montserrat Romero, Sónia R Veiga, et al.
Journal of Hepatology|June 6, 2015
Ursodeoxycholic acid inhibits hepatic cystogenesis in experimental models of polycystic liver diseasePatricia Munoz-Garrido, José J G Marin, María J Perugorria, et al.
Nature Reviews. Gastroenterology & Hepatology|April 21, 2016
Expert consensus document: Cholangiocarcinoma: current knowledge and future perspectives consensus statement from the European Network for the Study of Cholangiocarcinoma (ENS-CCA)Jesus M Banales, Vincenzo Cardinale, Guido Carpino, et al.
Forest Policy and Economics|March 7, 2020
Assessing forest availability for wood supply in EuropeI Alberdi, S Bender, T Riedel, et al.
Hepatology (Baltimore, Md.)|May 31, 2017
Serum extracellular vesicles contain protein biomarkers for primary sclerosing cholangitis and cholangiocarcinomaAnder Arbelaiz, Mikel Azkargorta, Marcin Krawczyk, et al.
British Journal of Cancer|July 23, 2020
Current and novel therapeutic opportunities for systemic therapy in biliary cancerJosé J G Marin, Maria Giuseppina Prete, Angela Lamarca, et al.
Hepatology (Baltimore, Md.)|April 8, 2022
Beneficial effect of ursodeoxycholic acid in patients with acyl-CoA oxidase 2 (ACOX2) deficiency-associated hypertransaminasemiaMarta Alonso-Peña, Ricardo Espinosa-Escudero, Elisa Herraez, et al.
Pageof 46

Showing results (421-430 of 453) with videos related to

Sort By:
Pageof 46
Hepatology (Baltimore, Md.)|September 19, 2017
MicroRNA-506 promotes primary biliary cholangitis-like features in cholangiocytes and immune activationOihane Erice, Patricia Munoz-Garrido, Javier Vaquero, et al.
Journal of Hepatology|June 24, 2022
TREM-2 plays a protective role in cholestasis by acting as a negative regulator of inflammationIbone Labiano, Aloña Agirre-Lizaso, Paula Olaizola, et al.
Clinical Science (London, England : 1979)|September 20, 2024
Non-mitogenic FGF19 mRNA-based therapy for the treatment of experimental metabolic dysfunction-associated steatotic liver disease (MASLD)Amaya Lopez-Pascual, Joan S Russo-Cabrera, Nuria Ardaiz, et al.
Nature Communications|September 4, 2025
Identification of Neuritin 1 as a local metabolic regulator of brown adipose tissueManuela Sánchez-Feutrie, Montserrat Romero, Sónia R Veiga, et al.
Journal of Hepatology|June 6, 2015
Ursodeoxycholic acid inhibits hepatic cystogenesis in experimental models of polycystic liver diseasePatricia Munoz-Garrido, José J G Marin, María J Perugorria, et al.
Nature Reviews. Gastroenterology & Hepatology|April 21, 2016
Expert consensus document: Cholangiocarcinoma: current knowledge and future perspectives consensus statement from the European Network for the Study of Cholangiocarcinoma (ENS-CCA)Jesus M Banales, Vincenzo Cardinale, Guido Carpino, et al.
Forest Policy and Economics|March 7, 2020
Assessing forest availability for wood supply in EuropeI Alberdi, S Bender, T Riedel, et al.
Hepatology (Baltimore, Md.)|May 31, 2017
Serum extracellular vesicles contain protein biomarkers for primary sclerosing cholangitis and cholangiocarcinomaAnder Arbelaiz, Mikel Azkargorta, Marcin Krawczyk, et al.
British Journal of Cancer|July 23, 2020
Current and novel therapeutic opportunities for systemic therapy in biliary cancerJosé J G Marin, Maria Giuseppina Prete, Angela Lamarca, et al.
Hepatology (Baltimore, Md.)|April 8, 2022
Beneficial effect of ursodeoxycholic acid in patients with acyl-CoA oxidase 2 (ACOX2) deficiency-associated hypertransaminasemiaMarta Alonso-Peña, Ricardo Espinosa-Escudero, Elisa Herraez, et al.
Pageof 46